The collaboration leverages the scientific knowledge, expertise and translational research capabilities of Helmholtz Zentrum München researchers and Novo Nordisk’s extensive know-how within research, clinical development and commercialization of pharmaceutical products against chronic metabolic diseases.
Helmholtz Zentrum München and Novo Nordisk extended their research collaboration in metabolic diseases
Transfer